Polaryx Therapeutics, Inc. (PLYX)

Polaryx Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Polaryx Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Debt / Equity Ratio	0.00	0.03	0.37
Debt / EBITDA Ratio	-0.02	0.00	-0.13
Debt / FCF Ratio	-0.05	-0.05	-2.76
Quick Ratio	8.42	15.99	0.00
Return on Equity (ROE)	8.37%	-644.23%	-295.93%
Return on Assets (ROA)	-	-607.00%	-163.24%
Return on Capital (ROIC)	7.79%	-89.88%	-215.44%
Return on Capital Employed (ROCE)	1204.25%	-644.23%	-295.93%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).